WIRB-Copernicus Group Thought Leaders to Present at 50th Annual Drug Information Association Conference - KXNet.com - Bismarck/Minot/Williston/Dickinson-KXNEWS,ND

WIRB-Copernicus Group Thought Leaders to Present at 50th Annual Drug Information Association Conference

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE WIRB-Copernicus Group

PRINCETON, N.J., June 13, 2014 /PRNewswire/ -- WIRB-Copernicus Group ("WCG"), the world's largest provider of regulatory and ethical review services for clinical research, announced today that three of its thought leaders will be presenting at the 50th Annual Drug Information Association (DIA) Annual Meeting. It will be held at the San Diego Convention Center, San Diego, CA from June 15-19.

WCG Logo

WCG Chief Clinical Research Officer and President, Consulting Services Lindsay McNair, MD, MPH, MSB, will address: "Improving Communication in the Informed Consent Process: The Advantages of eConsent" from 10:30 a.m.-12 p.m. on June 17 in room 16A.

Later on June 17, Chris Jenkins, PhD, MPH, RBP, CHMM, the WCG senior director of IBC services and biosafety consulting, will participate in a symposium entitled, "Human Gene Therapy: Biosafety to Bedside." That session will be held from 3:30-5 p.m. in room 7B.

Then on June 19, Stuart Horowitz, PhD, MBA, WCG president of institutions and institutional services will lead a workshop on, "Accelerating Research in a Large Health Care System: Streamlining Research Review and Study Initiation" from 9-10:30 a.m. in room 16A.

"Ethical and regulatory reviews are complex disciplines. It is important that we keep sharing key learnings with our peers to ensure that we all continue not only to provide the best possible safeguards for human subjects in clinical research, but also to do so with the efficiencies of best practices," said Dr. Horowitz.

WCG will also be giving demonstrations of WCG eConsent, powered by Mytrus®, an electronic informed-consent solution delivered via an iPad®, and WCG Academy, the company's online learning solution for clinical research professionals, in the DIA exhibit hall at booth #1205.

Additionally, the company will host a celebration for all DIA conference attendees on Tuesday, June 17 at 6:30 p.m. at the Hotel del Coronado. Attendees can register for the WCG Beach Party event at www.wcgbeachparty.com.

For more information about the 50th Annual DIA Meeting, please visit: http://www.diahome.org/Home/Flagship-Meetings/DIA2014.aspx.

About The WIRB-Copernicus Group
The WIRB-Copernicus Group (WCG) is the world's largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG's solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials.

WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life.

For more information, please visit www.wcgclinical.com.

Logo - http://photos.prnewswire.com/prnh/20140422/77410 

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
General information or questions:

Phone: 701-223-9197
News Fax: 701-223-1985

Phone: 701-852-2104
News Fax: 701-838-1050
All content © Copyright 2000 - 2014 WorldNow and KXNET. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.